Dr Gary Wilson
Gary's expertise covers the chemical, pharmaceutical and mechanical fields. He acts for a diverse range of companies across these technologies. He is also Head of the HGF Chemistry Team.
In particular, Gary has advised clients on numerous technologies including: catalysis; chemical synthesis; cosmetics; fabrics; fuel cells; medical devices; oil and gas technology; optics; nanotechnology; polymer materials; renewables; semiconductors and solar cells.
Gary provides commercially focussed advice to a range of organisations. This has included advising on all aspects of patent filing strategies, freedom- to-operate opinions, infringement and validity opinions, due diligence, licensing issues and enforcement of patent rights.
He also regularly represents clients in Opposition and Appeal Proceedings before the European Patent Office and is highly sought after by clients due to his advocacy skills in both defending and opposing European patents. He is also experienced in UK patent litigation and instructing foreign counsel on world-wide litigation matters. Gary is also one of the limited number of UK patent professionals recommended in the IAM 1000 - the international guide to the world’s leading IP professionals - for 2013 to 2016. In 2014, 2015 and 2016 Gary was also listed as a Managing Intellectual Property (MIP) Star.
Gary is personally mentioned and recommended in leading directories such as the Legal 500 and Managing Intellectual Property. He also led the firm to winning the Managing Intellectual Property 2011 and 2012 Scottish IP Firm of Year Awards. The Legal 500 recommends Gary as being “bright, intelligent and dedicated”.
Gary graduated from the University of Glasgow with a first class honours degree and doctorate in Chemistry. He was also awarded the Joseph Black Medal in Chemistry. Gary also studied Intellectual Property Law at Queen Mary and Westfield College, University of London.
He joined HGF as a partner in 2007 to open and manage the firm’s first Scottish office. During this time he has sat on the firm’s Strategy Group and International Review Committee. In addition to being a regular speaker at events and writing many articles he is also a board member of a UK science development organisation.